Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Loneliness and Aspergillosis
November 30, 2022
Doing a disability assessment
November 21, 2022
Finding an advocate
November 21, 2022
Managing breathlessness
November 18, 2022
Sex and breathlessness
November 18, 2022
Managing Chronic Pain
November 18, 2022
Recognising and avoiding depression
November 18, 2022
Plugs and Slugs
November 10, 2022
Living with CPA and ABPA
October 31, 2022
Rare disease patient journey to diagnosis
October 24, 2022
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video